+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Expression of the ligand-binding domain-containing region of retinoic acid receptors alpha, beta and gamma in Escherichia coli and evaluation of ligand-binding selectivity



Expression of the ligand-binding domain-containing region of retinoic acid receptors alpha, beta and gamma in Escherichia coli and evaluation of ligand-binding selectivity



Biological and Pharmaceutical Bulletin 16(4): 343-348



The complete molecule or the ligand-binding domain-containing region of each of the three subtypes of human retinoic acid receptors (hRAR alpha, hRAR beta and hRAR gamma) was expressed in Escherichia coli. The expressed recombinant RARs (rRARs: rRAR alpha/E, rRAR beta/E and rRAR gamma) showed nearly the same magnitude of binding affinity toward [3H]retinoic acid (RA) as hRARs extracted from human cells (Ka values: 6.0 x 10(9) M-1 for rRAR alpha/E and 2.7 x 10(10) M-1 for both rRAR beta/E and rRAR gamma). Therefore, the ligand-binding selectivity of the rRARs toward RA and synthetic retinoids (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenylcarbamoyl )benzoic acid (Am80), (E)-4-[3-(3,5-di-tert-butylphenyl)-3-oxo-1-propenyl]benzoic acid (Ch55)) was examined. Am80 bound rRAR alpha/E preferentially and showed no binding activity toward rRAR gamma, which is consistent with the case of hRAR gamma. Ch55 bound all three subtypes of rRARs, preferentially rRAR beta/E. These results suggest that the intrinsic nature of the binding of each retinoid can be investigated by usage of the rRARs. However, rRARs show quantitatively different ligand-selectivity from that of hRARs: RA showed higher binding affinity toward rRARs than both Am80 and Ch55, but Ch55 binds all three subtypes of hRARs stronger than RA and Am80, which binds hRAR beta stronger than RA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008664521

Download citation: RISBibTeXText

PMID: 8395280

DOI: 10.1248/bpb.16.343


Related references

Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Escherichia coli. Biochemical Journal 308: 353-359, 1995

The ligand binding domain of the human retinoic acid receptor gamma is predominantly alpha-helical with a Trp residue in the ligand binding site. Journal of Biological Chemistry 270(42): 24884-24890, 1995

Expression of human all-trans -retinoic acid receptor and its ligand-binding domain in Escherichia coli. Biochemical Journal 308(1): 353-359, 1995

Ligand- and subunit-specific conformational changes in the ligand-binding domain and the TM2-TM3 linker of {alpha}1 {beta}2 {gamma}2 GABAA receptors. Journal of Biological Chemistry 285(51): 40373-40386, 2010

Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity. Protein Expression and Purification 6(3): 363-370, 1995

Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's). Biochemical and Biophysical Research Communications 166(3): 1300-1307, 1990

The ligand binding domain of the human retinoic acid receptor-gamma recognizes a chiral, ligand. Journal of Cellular Biochemistry Suppl. 0(17 Part A): 167, 1993

Effects of co-expression of liver X receptor β-ligand binding domain with its partner, retinoid X receptor α-ligand binding domain, on their solubility and biological activity in Escherichia coli. Journal of Microbiology and Biotechnology 25(2): 247-254, 2015

Mutagenesis of the ligand binding domain of the human retinoic acid receptor alpha identifies critical residues for 9-cis-retinoic acid binding. Journal of Biological Chemistry 270(35): 20258-20263, 1995

The ligand binding domain of the human retinoic acid receptor c is predominantly a-helical with a Trp residue in the ligand binding site. The Journal of Biological Chemistry 270: 884-90, 1995

Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia. Blood 96(9): 3200-3208, 2000

Expression of human peroxisome proliferator-activated receptors ligand binding domain-maltose binding protein fusion protein in Escherichia coli: a convenient and reliable method for preparing receptor for screening ligands. Assay and Drug Development Technologies 6(6): 803-810, 2008

Purification and functional characterization of the ligand-binding domain from the retinoic acid receptor alpha: Evidence that sulfhydryl groups are involved in ligand-receptor interactions. Biochemistry 32(46): 12428-12436, 1993

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9(8): 699-706, 2001

Co-repressor release but not ligand binding is a prerequisite for transcription activation by human retinoid acid receptor alpha ligand-binding domain. Journal of Biological Chemistry 278(9): 7366-7373, 2003